An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibition

An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibition

Not available.

Saved in:

Bibliographic Details
Main Authors:	Iman Sarami, Amy S. Duffield, Suchitra Sundaram, Douglas I. Lin, Christian Salib, Shafinaz Hussein, Siraj El Jamal, Nasrin Ghesani, Busra Cangut, Bruce E. Petersen
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-06-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/12133
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New Facets of Hematolymphoid Eponymic Diseases
by: Chi Sing Ng, et al.
Published: (2025-04-01)

A rare extramedullary and extralymphoid presentation of mixed phenotypic blastic hematolymphoid neoplasm: A study of two cases
by: Kiran Ghodke, et al.
Published: (2017-01-01)

A Case of an SMARCB1 (INI1)-Deficient Intrathoracic Neoplasm That Did Not Respond to Chemotherapy for Non-Small Cell Lung Cancer and Rapidly Progressed
by: Yutaro Moriyasu, et al.
Published: (2025-02-01)

Loss of SMARCB1 evokes targetable epigenetic vulnerabilities in epithelioid sarcoma
by: Jia Xiang Jin, et al.
Published: (2025-05-01)

Unclassifiable renal carcinoma with medullary phenotype and SMARCB1 deficiency: case report
by: Samya H. Mehanna, et al.
Published: (2025-06-01)

SMARCB1-deficient poorly differentiated testicular carcinoma: a case report
by: Zhiying Wang, et al.
Published: (2025-03-01)

SMARCB1 orchestrates cellular plasticity and oncogenic pathways in typical and chondroid chordomas
by: Weihai Liu, et al.
Published: (2025-06-01)

A novel mutation in SMARCB1 associated with adult Coffin-Siris syndrome and meningioma
by: Guo Zhenglong, et al.
Published: (2024-11-01)

INI1 (SMARCB1) deletion of lung cancer: a case report and literature review
by: Hong-Yan Ma, et al.
Published: (2024-12-01)

S-nitrosylation of EZH2 alters PRC2 assembly, methyltransferase activity, and EZH2 stability to maintain endothelial homeostasis
by: Ashima Sakhuja, et al.
Published: (2025-04-01)

Phenotypic manifestation of homozygous partial deletion of the chromosome 1 segment spanning <i>CFHR3</i> region
by: I. A. Tuzankina, et al.
Published: (2020-05-01)

Rapid development of homozygous lines through culture of isolated microspores in leafy crops of <i>Brassicaceae</i> Burnett
by: Elena A. Domblides, et al.
Published: (2019-09-01)

Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy
by: Turgut Bora Cengiz, et al.
Published: (2025-01-01)

Dual targeting of CXCR4 and EZH2 in endometriosis
by: Sarah Brunty, et al.
Published: (2025-04-01)

The epigenetic role of EZH2 in acute myeloid leukemia
by: Jinyong Fang, et al.
Published: (2024-12-01)

P868: Prenatal findings of mevalonate kinase deficiency in an MVK I268T homozygous fetus
by: Marek Svoboda, et al.
Published: (2025-01-01)

Wilson’s Disease Caused by Previously Undescribed Homozygous Nucleotide Variant of the <i>ATP7B</i> Gene: Clinical Cases
by: Denis K. Chernevskiy, et al.
Published: (2024-05-01)

Case Report: SMARCB1-deficient phenotype may be a new specialized type of pleomorphic xanthoastrocytoma associated with poor prognosis
by: Hui Zhang, et al.
Published: (2025-03-01)

SMARCB1- and vimentin-positive esophageal carcinoma with undifferentiated components, rhabdoid features, and a good prognosis: a case report
by: Hideki Nagano, et al.
Published: (2019-01-01)

Tertiary lymphoid structures potentially promote immune checkpoint inhibitor response in SMARCB1-deficient medullary renal cell carcinoma
by: Yanfeng Tang, et al.
Published: (2024-11-01)

Treatment of iatrogenic acute aortic type A aortic dissection complicating transcatheter aortic valve insertion: A case reportCentral Message
by: Busra Cangut, MD, et al.
Published: (2020-09-01)

YPEL2 regulates the efficacy of BRD4-EZH2 dual targeting in EZH2Y641mut germinal center-derived lymphoma
by: Aránzazu Chamorro-Jorganes, et al.
Published: (2025-03-01)

EZH2 loss promotes gastric squamous cell carcinoma
by: Mengsha Zhang, et al.
Published: (2025-07-01)

EZH2 expression is restricted to malignant salivary gland tumors
by: Dusit BUMALEE, et al.
Published: (2025-06-01)

The Role of EZH2 in Initiating Epigenetic Regulation of CRSwNP
by: Zeng R, et al.
Published: (2025-07-01)

EZH2 mutations increase the heterogeneity of chromatin states in lymphoma
by: Daniel Holoch, et al.
Published: (2025-06-01)

Research progress of EZH2 in non-tumor renal diseases
by: Wang Hui, et al.
Published: (2025-05-01)

EZH2 mutations increase the heterogeneity of chromatin states in lymphoma.
by: Daniel Holoch, et al.
Published: (2025-06-01)

Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential
by: Maria Saveria Gilardini Montani, et al.
Published: (2024-12-01)

Dysregulation of T Follicular Helper and Regulatory Cells in <i>IRF5</i>-SLE Homozygous Risk Carriers and Systemic Lupus Erythematosus Patients
by: Bharati Matta, et al.
Published: (2025-03-01)

Strategies for identifying <i>NUP98</i> rearrangements in adult myeloid neoplasms
by: Lisa D. Yuen, et al.
Published: (2025-08-01)

Efficacy of glutathione inhibitor eprenetapopt against the vulnerability of glutathione metabolism in SMARCA4-, SMARCB1- and PBRM1-deficient cancer cells
by: Mariko Sasaki, et al.
Published: (2024-12-01)

Maternal Uniparental Isodisomy of Chromosome 2 Leading to Homozygous Variants in <i>SPR</i> and <i>ZNF142</i>: A Case Report and Review of the UPD2 Literature
by: Janhawi Kelkar, et al.
Published: (2024-01-01)

<i>CDKN2A</i> Homozygous Deletion Is a Stronger Predictor of Outcome than <i>IDH1/2</i>-Mutation in CNS WHO Grade 4 Gliomas
by: Sang Hyuk Lee, et al.
Published: (2024-10-01)

EZH2 expression in colorectal carcinoma: an evaluation of clinicopathological and prognostic value
by: Diren Vuslat Cagatay, et al.
Published: (2025-06-01)

Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon
by: Toshinori Kobayashi, et al.
Published: (2023-02-01)

SMARCB1 Deficiency as a Driver of the Hallmarks of Cancer in Rhabdoid Tumours: Novel Insights into Dysregulated Energy Metabolism, Emerging Targets, and Ongoing Clinical Trials
by: Abdul L. Shakerdi, et al.
Published: (2025-05-01)

Analysis of occlusal characteristics of identical homozygous twins
by: Kučević Esad, et al.
Published: (2017-01-01)

Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features.
by: Yung-Luen Yu, et al.
Published: (2014-01-01)

ROS regulates circadian rhythms by modulating Ezh2 interactions with clock proteins
by: Hao-yi Zhang, et al.
Published: (2025-04-01)